Insight

Filippo Montemurro: Would This Point at a Space for Non Pharmacological Interventions?

Filippo Montemurro/LinkedIn

Aug 23, 2025, 18:51

Filippo Montemurro: Would This Point at a Space for Non Pharmacological Interventions?

Filippo Montemurro, Senior Medical Director at Roche, shared on X about a recent paper by Fatima Cardoso et al. published on NEJM:

“Interesting to see that also placebo has activity in reducing Vasomotor Symptoms from Endocrine Therapy for Breast Cancer. Would this point at a space for non pharmacological interventions? | New England Journal of Medicine.”

Title: Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

Authors: Fatima Cardoso, Susanne Parke, Donal J. Brennan, Paula Briggs, Gilbert Donders, Nick Panay, Nazanin Haseli-Mashhadi, Michael Block, Cecilia Caetano, Maja Francuski, Claudia Haberland, Kaisa Laapas, Christian Seitz, Lineke Zuurman

Read the full article.

Filippo Montemurro

More posts featuring Filippo Montemurro.

Cecilia Caetano Christian Seitz Claudia Haberland Donal J. Brennan Fatima Cardoso Filippo Montemurro Gilbert Donders Kaisa Laapas Lineke Zuurman Maja Francuski Michael Block Nazanin Haseli Mashhadi Nick Panay Paula Briggs Susanne Parke

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark